Search results for " malattie."

showing 10 items of 1941 documents

Mild obstructive sleep apnea increases hypertension risk, challenging traditional severity classification

2020

STUDY OBJECTIVES: The association of mild obstructive sleep apnea (OSA) with important clinical outcomes remains unclear. We aimed to investigate the association between mild OSA and systemic arterial hypertension (SAH) in the European Sleep Apnea Database cohort. METHODS: In a multicenter sample of 4,732 participants, we analyzed the risk of mild OSA (subclassified into 2 groups: mild(AHI 5-<11/h) (apnea-hypopnea index [AHI], 5 to <11 events/h) and mild(AHI 11-<15/h) (AHI, ≥11 to <15 events/h) compared with nonapneic snorers for prevalent SAH after adjustment for relevant confounding factors including sex, age, smoking, obesity, daytime sleepiness, dyslipidemia, chronic obstructive pulmona…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyEuropean Sleep Apnea Database Mild obstructive sleep apnea Systemic arterial hypertensionPolysomnographyDisorders of Excessive SomnolenceSettore MED/10 - Malattie Dell'Apparato RespiratorioHypertension risk03 medical and health sciences0302 clinical medicinestomatognathic systemRisk FactorsInternal medicinesystemic arterial hypertensionmedicineHumansEuropean Sleep Apnea DatabaseSleep Apnea ObstructiveSystemic arterial hypertensionbusiness.industrymedicine.diseaseScientific InvestigationsClinical neurologyrespiratory tract diseasesnervous system diseasesObstructive sleep apneamild obstructive sleep apneaDiabetes Mellitus Type 2NeurologyHypertensionNeurology (clinical)Human medicinebusiness030217 neurology & neurosurgery
researchProduct

Comment to the Editorial by KS Park and EW Kang “Is only fixed positive airway pressure a robust tool for kidney protection in patients with obstruct…

2019

We thank doctors Park and Kang for their editorial that well summarized our article. Our common belief is that one of the possible consequences of untreated obstructive sleep apnea (OSA) is an accelerated deterioration of kidney function, and that more knowledge would be necessary on the possible protective effects of OSA treatments. To our knowledge, so far the only OSA therapy whose effects on renal function have been tested is continuous positive airway pressure (CPAP), and most , although not all studies, have demonstrated its benefits. Our own study, while confirming benefits of fixed CPAP, has demonstrated little effect of auto-adjusting CPAP (APAP). This finding may be of relevance a…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyLetterestimated glomerular filtration ratekidney diseaseRenal functionPolysomnographySettore MED/10 - Malattie Dell'Apparato Respiratoriosleep disordered breathingpolysomnographyrenal protectionPositive airway pressureMedicineIn patienthumansleepIntensive care medicinekidney functionLetter to the EditorPositive end-expiratory pressureKidneymedicine.diagnostic_testbusiness.industryobstructive sleep apnea ; kidney protection ; fixed positive airway pressuremedicine.diseaseoxygen saturationrespiratory tract diseasesObstructive sleep apneaNot availablemedicine.anatomical_structureEditorialpositive end expiratory pressureHuman medicinebusinesschronic obstructive lung diseaseKidney disease
researchProduct

Challenges and perspectives in obstructive sleep apnoea: Report by an ad hoc working group of the Sleep Disordered Breathing Group of the European Re…

2018

Obstructive sleep apnoea (OSA) is a major challenge for physicians and healthcare systems throughout the world. The high prevalence and the impact on daily life of OSA oblige clinicians to offer effective and acceptable treatment options. However, recent evidence has raised questions about the benefits of positive airway pressure therapy in ameliorating comorbidities.An international expert group considered the current state of knowledge based on the most relevant publications in the previous 5 years, discussed the current challenges in the field, and proposed topics for future research on epidemiology, phenotyping, underlying mechanisms, prognostic implications and optimal treatment of pat…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyMEDLINEPolysomnographySettore MED/10 - Malattie Dell'Apparato Respiratoriosleepinesslaw.invention03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Randomized controlled trialstomatognathic systemlawPositive airway pressureEpidemiologyMedicineIntensive care medicinesleep apnea: obstructivemedicine.diagnostic_testbusiness.industrySleep apneamedicine.diseaseComorbiditynervous system diseasesrespiratory tract diseasesdiagnosi030228 respiratory systemHuman medicinebusiness030217 neurology & neurosurgerysleep apnea phenotyping mechanisms
researchProduct

What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis

2020

Abstract Background The choice of inhaler device for asthma patients depends upon multiple attributes. We investigated factors that may drive general practitioners (GPs) and respiratory specialists in the prescription of inhaler devices for asthma patients who initiated inhalation therapy. Methods We retrospectively analysed prescriptions by GPs and respiratory specialists to asthma patients commencing inhaled corticosteroid/long-acting β2-agonist combination therapy available as both pressurised metered-dose inhalers (pMDIs) and dry powder inhalers (DPIs). Patient characteristics were compared by device and multivariate analysis was used to model the likelihood of receiving a pMDI as oppos…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyMultivariate analysisSettore MED/10 - Malattie Dell'Apparato RespiratorioGeneral practitioner03 medical and health sciencesdry powder inhaler0302 clinical medicineInhalersAdrenal Cortex HormonesAdrenergic beta-2 Receptor AntagonistsAsthma controlGeneral practitionersAdministration InhalationRetrospective analysisMedicine030212 general & internal medicineMetered Dose InhalersMedical prescriptionAsthmaRetrospective Studiesbusiness.industryInhalerdry powder inhalersInhalerOdds ratiomedicine.diseaseConfidence intervalAsthmaPressurised metered-dose inhalerAsthma; dry powder inhalers; General practitioners; Inhalers; Pressurised metered-dose inhalers; Respiratory specialistsPrescriptions030228 respiratory systemRespiratory specialistsInhalationDelayed-Action PreparationsEmergency medicineAdministrationPressurised metered-dose inhalersbusinessAsthma; dry powder inhalers; General practitioners; Inhalers; Pressurised metered-dose inhalers; Respiratory specialists; Administration Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Antagonists; Asthma; Delayed-Action Preparations; Retrospective Studies; Dry Powder Inhalers; Metered Dose Inhalers; Prescriptions
researchProduct

Third-hand smoke exposure and health hazards in children

2013

Smoking still represents a huge public health problem. Millions of children suffer the detrimental effects of passive smoking. An increasing number of countries have recently issued laws to regulate smoking in public places. Instead, homes remain a site where children are dangerously exposed to environmental tobacco smoke (ETS). The combination of tobacco smoke pollutants which remain in an indoor environment, the so-called ‘third-hand smoke’ (THS), represent a new concept in the field of tobacco control. THS consists of pollutants that remain on surfaces and in dust after tobacco has been smoked, are re-emitted into the gas-phase, or react with other compounds in the environment to form se…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPassive smokinglcsh:MedicineSettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.disease_causeTobacco smokeHazardous SubstancesThird-hand smokeSettore MED/38 - Pediatria Generale E SpecialisticaEnvironmental tobacco smokeEnvironmental healthmedicineHumansEnvironmental tobacco smoke Children Lung development Asthma Tobacco control Indoor environment Third-hand smoke.Active smokingThird-hand smokeChildChildrenSmokebusiness.industryPublic healthTobacco controllcsh:RIndoor environmentThird-hand smoke.AsthmaHuman exposureLung developmentTobacco Smoke PollutionTobacco controlCardiology and Cardiovascular Medicinebusiness
researchProduct

Arterial stiffness in symptomatic smokers with normal lung function

2017

Chronic obstructive pulmonary disease (COPD) is associated with cardiovascular morbidity and mortality. Arterial stiffness and endothelial dysfunction index are validated surrogate cardiovascular markers and are increased in subjects with COPD. We tested whether increased arterial stiffness and endothelial dysfunction occur in symptomatic smokers with no evidence of bronchial obstruction. Clinical and lung functional assessments were conducted in smoker subjects with chronic respiratory symptoms and in COPD patients. Pulse wave velocity (PWV), aortic augmentation index (AIx) and reactive hyperaemia index (RHI) were measured to estimate the cardiovascular risk. 48 smokers (male n=37, female …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPathology1lcsh:Medicine030204 cardiovascular system & hematologySettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciencesHyperaemia0302 clinical medicineInternal medicinemedicineEndothelial dysfunctionRespiratory systemPulse wave velocityCOPDLungbusiness.industrylcsh:ROriginal ArticlesAortic Augmentation Indexmedicine.diseaserespiratory tract diseasesmedicine.anatomical_structure030228 respiratory systemCardiologyArterial stiffnessmedicine.symptombusiness
researchProduct

Eligibility of real-life patients with copd for inclusion in rcts: A commentary

2017

Randomized clinical trials (RCTs) are performed to provide evidence to support treatment decisions. Based on the nature of those studies and the need to avoid confounding factors, it has been argued that the population selected in RCTs only partially represents the real-life population. This assumption casts doubts on the applicability of the results provided by RCTs in the management of individuals with an established diagnosis of COPD, and advocates the need for complementary studies with a pragmatic design. Herein, we comment on the recent article published by Halpin and colleagues on the Journal [Halpin et al, Respir Res 17:120, 2016], in which higher rates of inclusions in RCTs for COP…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPediatricsInclusion (disability rights)PopulationAlternative medicineEligibility DeterminationCOPD researchClinical practiceSettore MED/10 - Malattie Dell'Apparato Respiratoriolaw.inventionPulmonary Disease Chronic Obstructive03 medical and health sciencesClinical trials0302 clinical medicineRandomized controlled triallawHumansMedicine030212 general & internal medicineEligibility DeterminationIntensive care medicineeducationRandomized Controlled Trials as TopicCOPDeducation.field_of_studybusiness.industryPatient SelectionConfoundingmedicine.diseaseClinical trialClinical trial030228 respiratory systemCommentaryClinical practice; Clinical trials; COPD research; Pulmonary and Respiratory Medicinebusiness
researchProduct

The value of FeNO measurement in childhood asthma: uncertainties and perspectives

2013

Asthma is considered an heterogeneous disease, requiring multiple biomarkers for diagnosis and management. Fractional exhaled nitric oxide in exhaled breath (FeNO) was the first useful non-invasive marker of airway inflammation in asthma and still is the most widely used. The non-invasive nature and the relatively easy use of FeNO technique make it an interesting tool to monitor airway inflammation and rationalize corticosteroid therapy in asthmatic patients, together with the traditional clinical tools (history, physical examination and lung function tests), even if some controversies have been published regarding the use of FeNO to support the management of asthma in children. The problem…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPediatricsPopulationexhaled nitric oxide asthma children pollutionContext (language use)ReviewDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioPulmonary function testing03 medical and health sciences0302 clinical medicineSettore MED/38 - Pediatria Generale E Specialisticachildrenmedicinepollution030212 general & internal medicineIntensive care medicineeducationFENO; Childhood asthmaAsthmaeducation.field_of_studybusiness.industryConfoundingasthmarespiratory systemmedicine.disease3. Good healthrespiratory tract diseases030228 respiratory systemExhaled nitric oxideexhaled nitric oxideBiomarker (medicine)businessMultidisciplinary Respiratory Medicine
researchProduct

EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke.

2020

BACKGROUND Sleep disorders are highly prevalent in the general population and may be linked in a bidirectional fashion to stroke, which is one of the leading causes of morbidity and mortality. AIM Four major scientific societies established a task force of experts in neurology, stroke, respiratory medicine, sleep medicine and methodology to critically evaluate the evidence regarding potential links and the impact of therapy. MATERIALS AND METHODS Thirteen research questions were evaluated in a systematic literature search using a stepwise hierarchical approach: first, systematic reviews and meta-analyses; second, primary studies post-dating the systematic reviews/meta-analyses. A total of 4…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPeriodic limb movement disorderNeurologymedicine.medical_treatmentinsomniaPopulationsleep apnea RLS insomnia strokerestless legs030204 cardiovascular system & hematologySettore MED/10 - Malattie Dell'Apparato RespiratorioSleep medicine03 medical and health sciencessleep disordered breathing0302 clinical medicineRestless Legs SyndromeSleep Initiation and Maintenance DisordersInsomniamedicinePrevalenceinsomnia outcome PLMS restless legs risk sleep disordered breathing sleep disorders strokeHumansContinuous positive airway pressure030212 general & internal medicineRisk factoreducationIntensive care medicinePLMSStrokeriskeducation.field_of_studySleep disorderSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryMiddle Agedmedicine.diseasestrokeStrokeSystematic reviewNeurologyMeta-analysisoutcomesleep disordersNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgeryThe European respiratory journal
researchProduct

Reliability of automatic detection of AHI during positive airway pressure treatment in obstructive sleep apnea patients: A “real-life study”

2021

Introduction: Automatic event detection (AED) of residual apnea-hypopnea index (AHI) by ventilators is a current practice in sleep and mechanical ventilation Units but this methodology has not been validated in an unselected population of OSA patients. Aim of the present study was to assess in a “real-life” condition the reliability of AED during PAP therapy by the in-built software compared to full polysomnography during follow-up. Methods: We enrolled 300 OSA patients (105 F; AHI 45.3 ± 27.8) already on Positive airway pressure (PAP) therapy: 53% of the patients were on CPAP while other modalities were used in the rest of the sample. Results: Overall, the built-in software identified resi…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPolysomnographymedicine.medical_treatmentPolysomnographySettore MED/10 - Malattie Dell'Apparato RespiratorioResidualLikelihood ratios in diagnostic testingOSA03 medical and health sciencesResidual OSA0302 clinical medicineCPAPInternal medicinePositive airway pressuremedicine030212 general & internal medicineMechanical ventilationmedicine.diagnostic_testbusiness.industryEpworth Sleepiness ScaleSleep apnea.medicine.diseaserespiratory tract diseasesObstructive sleep apnea030228 respiratory systemBreathingCardiologybusinessRespiratory Medicine
researchProduct